Castle Biosciences Inc — Statistiche Finanziarie Trimestrali (NASDAQ:CSTL) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative 24.36 M-6.04 M20.82 M22.63 M26.93 M 64.35 M Flussi di cassa derivanti dalle attività di investimento 5.77 M-22.43 M-28.38 M-18.39 M8.83 M -60.37 M Liquidità derivante dalle attività di finanziamento -5.38 M-1.55 M101 K-919 K-4.59 M -6.96 M Liquidità libera 16.8 M-10.78 M11.56 M7.8 M19.75 M 28.33 M

Notizie

Il CEO di Castle Biosciences Maetzold vende azioni per 106.598$

Castle Biosciences: Buying The Remaining DecisionDx-Melanoma Upside (NASDAQ:CSTL)

Castle Biosciences, Inc. (CSTL) Discusses Clinical Utility and Evidence Supporting DecisionDx Melanoma Test and DECIDE Study Transcript

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

AstraZeneca's Imfinzi Secures Approval for Gastric Cancer in the EU

FDA Approves NVS' Cosentyx in Hidradenitis Suppurativa for Adolescents

United Therapeutics Stock Surges 32% in 6 Months: Here's Why

Beam Therapeutics Stock Surges 23% in 6 Months: What's Driving It?

JNJ Seeks Label Expansion of Multiple Myeloma Drug Tecvayli in the EU

Stokes Frank vende titoli Castle Biosciences (CSTL) per 192.000$

Stokes Frank sells Castle Biosciences (CSTL) stock worth $192k

LLY Wins CHMP Nod for Olumiant's Expanded Use in Alopecia Areata